American Joint Committee on Cancer. See http://www.cancerstaging.org
2.
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology – Melanoma2006. See http://www.nccn.org
3.
BalchCM, SoongS, RossMI, Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanoma (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol2000; 7: 87–97
4.
KoopsHS, VaglianiM, SuciuS, Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group 8593. J Clin Oncol1998; 16: 2906–12
5.
RobertsDL, AnsteyAV, BarlowRJ, UK guidelines for the management of cutaneous melanoma. Br J Dermatol2002; 146: 7–17
